PSA Flags Dead, Child Payees in VP Sara Duterte’s Confidential Fund Transfers

PSA flags dead, child payees in VP Sara Duterte’s confidential fund transfers

A PHILIPPINE Statistics Authority (PSA) witness told the Senate impeachment court that civil registry records showed one listed recipient of Vice-President (VP) Sara Duterte-Carpio’s confidential funds was a two-month-old child who died in 1965, while other listed payees were also minors. Assistant National Statistician Marizza B. Grande confirmed the civil registry record during Monday’s impeachment […]

Names in acknowledgement receipts 'aliases' — Sara Duterte defense

The defense counsel of VP Sara Duterte clarifies longstanding question on the names appearing in the acknowledgement receipts for the confidential funds of DepEd, OVP

What’s Happening in Philippine Vice President Sara Duterte’s Impeachment Trial?

The trial has dropped from the headlines amid ongoing corruption controversies and the massive flooding that hit vast areas of Luzon this month.

PSA official to testify on Duterte's confidential fund recipient list

MANILA, Philippines — The Senate Impeachment Court will resume the trial of Vice President Sara Duterte on Monday, Sept. 7, 2026, with Philippine Statistics Authority (PSA) Assistant National Statistician Marizza Grande testifying on the verification of names that appeared in acknowledgment receipts submitted by the Office of the Vice President (OVP) and the Department of Education (DepEd) to account for confidential fund expenditures.Grande is …

Sara Duterte impeachment trial | Sept. 7, 2026

This report is part of Inquirer’s special coverage of Vice President Sara Duterte’s impeachment proceedings. For real-time updates, follow our live coverage of the impeachment. MANILA, Philippines – As Vice President Sara Duterte’s impeachment trial enters its 10th week on Monday, the House prosecution panel is set to focus on verifying the identities of recipients of her confidential

LIVE Coverage: Sara Duterte's impeachment trial, Sept. 7

Follow the trial, in context and in real time.